Quick Answer
Neuraxis, INC reported Cash and Equivalents of $4.97 million for fiscal year 2025.
Neuraxis, INC Cash and Equivalents — Annual History
| Fiscal Year | Cash and Equivalents | YoY Change |
|---|---|---|
| 2025 | $4.97M | +34.3% |
| 2024 | $3.70M | +4605.8% |
| 2023 | $78.6K | -89.7% |
| 2023 | $761.2K | +200.1% |
| 2022 | $253.7K | — |
Quarterly Cash and Equivalents
| Quarter Ending | Cash and Equivalents | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $4.38M | +1577.8% | -26.9% |
| June 30, 2025 | $5.99M | +239.2% | +198.6% |
| March 31, 2025 | $2.01M | +2353.0% | -45.8% |
| December 31, 2024 | $3.70M | +4605.8% | +1317.0% |
| September 30, 2024 | $260.9K | -65.7% | -85.2% |
| June 30, 2024 | $1.77M | +3331.7% | +2059.3% |
| March 31, 2024 | $81.8K | — | +4.1% |
| December 31, 2023 | $78.6K | -69.0% | -89.7% |
- Neuraxis, INC showed an increase of +34.3% in Cash and Equivalents compared to the prior fiscal year.
- Over the 2022–2025 period, Neuraxis, INC’s cash and equivalents has grown by 1857.1% (from $253.7 thousand to $4.97 million).
- The most recent figure is from Neuraxis, INC’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 19, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: